Newbridge Financial Services Group, Inc. - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 140 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2021. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q4 2022$25,440
-31.2%
1,500
-40.0%
0.02%
-31.8%
Q3 2022$37,000
-7.5%
2,500
-2.5%
0.02%
-12.0%
Q2 2022$40,000
-51.8%
2,564
-16.3%
0.02%
-39.0%
Q1 2022$83,000
-42.8%
3,064
-21.7%
0.04%
-39.7%
Q4 2021$145,000
-26.4%
3,914
-4.9%
0.07%
-44.7%
Q3 2021$197,000
+2088.9%
4,114
+1458.3%
0.12%
+1950.0%
Q2 2021$9,000
-18.2%
2640.0%0.01%
-25.0%
Q1 2021$11,000
-57.7%
264
-55.5%
0.01%
-61.9%
Q4 2020$26,000
+550.0%
593
+537.6%
0.02%
+425.0%
Q3 2020$4,000930.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q2 2021
NameSharesValueWeighting ↓
DFPG INVESTMENTS, LLC 456,390$5,541,0003.62%
DAFNA Capital Management LLC 173,914$1,890,0000.65%
One68 Global Capital, LLC 19,861$216,0000.47%
Diametric Capital, LP 51,982$565,0000.41%
ARK Investment Management 1,383,756$15,041,0000.38%
EAM Investors, LLC 52,833$574,0000.13%
HIGHLINE CAPITAL MANAGEMENT, L.P. 31,404$341,0000.05%
Nikko Asset Management Americas, Inc. 280,548$3,050,0000.05%
MGO ONE SEVEN LLC 14,900$161,0000.04%
Qube Research & Technologies Ltd 67,702$736,0000.02%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders